The American Journal of Sports Medicine,
Journal Year:
2024,
Volume and Issue:
52(12), P. 3130 - 3146
Published: Sept. 23, 2024
Background:
Osteoarthritis
(OA)
is
a
prevalent
and
disabling
disease
that
affects
significant
proportion
of
the
global
population.
Urine-derived
stem
cells
(USCs)
have
shown
great
prospects
in
treatment
OA,
but
there
no
study
has
compared
them
with
traditional
cells.
Purpose:
This
aimed
to
compare
therapeutic
efficacy
mechanisms
USCs
adipose-derived
(ADSCs)
for
OA
treatment.
Study
Design:
Controlled
laboratory
study.
Methods:
We
biological
properties
ADSCs
using
CCK-8,
colony
formation,
EdU,
adhesion,
apoptosis
assays.
evaluated
protective
effects
on
IL-1β–treated
chondrocytes
by
chemical
staining,
immunofluorescence,
Western
blotting.
assessed
chondrocyte
autophagy
transmission
electron
microscopy,
also
intra-articular
injections
gross,
histological,
micro–computed
tomography,
immunohistochemical
analyses
an
rat
model
induced
anterior
cruciate
ligament
transection.
Results:
showed
higher
proliferation,
DNA
synthesis,
anti-apoptotic
abilities
than
ADSCs.
Both
increased
expression
cartilage-specific
proteins
decreased
matrix
degradation–related
inflammatory
factors
chondrocytes.
had
greater
advantage
suppressing
MMP-13
enhanced
chondrocytes,
being
more
effective
The
inhibitor
3-MA
reduced
Conclusion:
To
our
knowledge,
this
first
explore
knee
Considering
superior
terms
noninvasive
acquisition,
high
cost-benefit
ratio,
low
ethical
concerns,
suggests
they
may
be
promising
option
under
rigorous
regulatory
pathways.
Clinical
Relevance:
cell
source
treat
strengthens
evidence
application
USCs.
International Journal of Oral Science,
Journal Year:
2024,
Volume and Issue:
16(1)
Published: Jan. 15, 2024
Abstract
Oral
diseases,
such
as
periodontitis,
salivary
gland
and
oral
cancers,
significantly
challenge
health
conditions
due
to
their
detrimental
effects
on
patient’s
digestive
functions,
pronunciation,
esthetic
demands.
Delayed
diagnosis
non-targeted
treatment
profoundly
influence
patients’
prognosis
quality
of
life.
The
exploration
innovative
approaches
for
early
detection
precise
represents
a
promising
frontier
in
medicine.
Exosomes,
which
are
characterized
nanometer-sized
extracellular
vesicles,
secreted
by
virtually
all
types
cells.
As
the
research
continues,
complex
roles
these
intracellular-derived
vesicles
biological
processes
have
gradually
unfolded.
Exosomes
attracted
attention
valuable
diagnostic
therapeutic
tools
ability
transfer
abundant
cargos
intricate
involvement
multiple
cellular
functions.
In
this
review,
we
provide
an
overview
recent
applications
exosomes
within
field
focusing
inflammation-related
bone
diseases
squamous
cell
carcinomas.
We
characterize
exosome
alterations
demonstrate
potential
biomarkers
diagnosis,
highlighting
indicators
diseases.
also
summarize
targeted
therapy
proposed
future
directions
use
clinical
treatment.
Heliyon,
Journal Year:
2025,
Volume and Issue:
11(4), P. e42509 - e42509
Published: Feb. 1, 2025
:Extracellular
vesicles
(EVs),
are
critical
mediators
of
intercellular
communication
and
exhibit
significant
potential
across
various
biomedical
domains.
These
nano-sized,
membrane-encapsulated
entities
have
captured
substantial
interest
due
to
their
diverse
roles
in
pathogenesis
promising
therapeutic
applications.
EVs
manage
numerous
physiological
processes
by
transferring
bioactive
molecules,
including
proteins,
lipids,
nucleic
acids,
between
cells.
This
review
delves
into
the
factors
influencing
properties
EVs,
such
as
temperature
stress
conditions,
which
collectively
influence
size,
composition,
functional
attributes.
We
also
describe
emerging
emphasizing
involvement
microbial
interactions,
immune
modulation,
antimicrobial
resistance
spread
innovative
diagnostic
instruments.
Despite
applications,
advancement
EV-based
therapies
faces
several
challenges,
will
be
discussed.
By
elucidating
these
elements,
we
aim
provide
a
comprehensive
overview
transformative
revolutionizing
diagnostics
therapeutics
medicine.
Abstract
Exosomes
are
nano-sized
membrane
extracellular
vesicles
which
can
be
released
from
various
types
of
cells.
originating
inflammatory
or
injured
cells
have
detrimental
effects
on
recipient
cells,
while
exosomes
derived
stem
not
only
facilitate
the
repair
and
regeneration
damaged
tissues
but
also
inhibit
inflammation
provide
protective
against
diseases,
suggesting
they
may
serve
as
an
alternative
strategy
transplantation.
a
fundamental
role
in
communication
between
through
transfer
proteins,
bioactive
lipids
nucleic
acids
(like
miRNAs
mRNAs)
This
significantly
impacts
both
physiological
pathological
functions
Nuclear
factor
erythroid
2–related
2
(Nrf2),
transcription
factor,
is
able
to
mitigate
damage
caused
by
oxidative
stress
signaling
pathways.
The
positive
resulting
activation
Nrf2
pathway
different
disorders
been
documented
literature.
Studies
confirmed
that
could
act
effective
agonists.
However,
limited
studies
explored
therapeutic
cell-derived
exosomes.
review
provides
comprehensive
overview
existing
knowledge
concerning
pathways
impact
exerted
cell
some
common
diseases.
Graphical
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(17), P. 9149 - 9149
Published: Aug. 23, 2024
Osteoarthritis
(OA)
is
a
leading
cause
of
pain
and
disability
worldwide
in
elderly
people.
There
critical
need
to
develop
novel
therapeutic
strategies
that
can
effectively
manage
improve
the
quality
life
for
older
Mesenchymal
stem
cells
(MSCs)
have
emerged
as
promising
cell-based
therapy
age-related
disorders
due
their
multilineage
differentiation
strong
paracrine
effects.
Notably,
MSC-derived
exosomes
(MSC-Exos)
gained
significant
attention
because
they
recapitulate
MSCs
into
benefits
without
causing
any
associated
risks
compared
with
direct
cell
transplantation.
These
help
transport
bioactive
molecules
such
proteins,
lipids,
nucleic
acids,
which
influence
various
cellular
processes
related
tissue
repair,
regeneration,
immune
regulation.
In
this
review,
we
provided
an
overview
MSC-Exos
considerable
treatment
option
osteoarthritis.
This
review
will
go
over
underlying
mechanisms
by
may
alleviate
pathological
hallmarks
OA,
cartilage
degradation,
synovial
inflammation,
subchondral
bone
changes.
Furthermore,
summarized
current
preclinical
evidence
highlighted
results
from
vitro
vivo
studies,
well
progress
clinical
trials
using
treat
OA.
Advanced Science,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 4, 2025
Abstract
Chondrocyte
senescence
is
an
important
pathogenic
factor
causing
osteoarthritis
(OA)
progression
through
persistently
producing
pro‐inflammatory
factors.
Mesenchymal
stem
cells‐derived
small
extracellular
vesicles
(MSC‐sEVs)
have
shown
anti‐inflammatory
effects
in
OA
models,
while
persistent
existence
of
senescent
chondrocytes
still
promotes
cartilage
destruction.
Therefore,
improving
the
targeted
elimination
ability
on
required
to
facilitate
translation
MSC‐sEVs
treatment.
In
this
study,
versatile
engineered
are
developed
targetedly
clear
and
maintain
metabolic
homeostasis.
Specifically,
loaded
with
siRNA
mouse
double
minute
2
homologue
(siMDM2)
modified
cartilage‐targeting
peptide
WYRGRL‐PEG
2K
‐DSPE
(WPD),
named
WPD‐sEVs
siMDM2
.
The
results
demonstrate
modification
improves
cellular
uptake
chondrocytes,
thus
antiaging
effects.
Importantly,
multifunctional
enhances
penetration
extends
joint
retention
time
MSC‐sEVs.
both
post‐traumatic
mice
naturally
aged
mice,
more
effectively
eliminates
maintained
matrix
By
using
P53
phosphorylation
inhibitor,
essential
role
MDM2‐P53
pathway
function
verified.
ex
vivo
cultured
human
explants,
it
confirmed
that
alleviates
phenotype.
Altogether,
findings
suggest
promising
translational
potential
for
Frontiers in Bioengineering and Biotechnology,
Journal Year:
2024,
Volume and Issue:
12
Published: March 20, 2024
Osteoarthritis
(OA)
is
the
most
common
degenerative
disease
of
joint
with
irreversible
cartilage
damage
as
main
pathological
feature.
With
development
regenerative
medicine,
mesenchymal
stem
cells
(MSCs)
have
been
found
to
strong
therapeutic
potential.
However,
intraarticular
MSCs
injection
therapy
limited
by
economic
costs
and
ethics.
Exosomes
derived
from
MSC
(MSC-Exos),
important
intercellular
communication
mode
MSCs,
contain
nucleic
acid,
proteins,
lipids,
microRNAs,
other
biologically
active
substances.
excellent
editability
specificity,
MSC-Exos
function
a
targeted
delivery
system
for
OA
treatment,
modulating
immunity,
inhibiting
apoptosis,
promoting
regeneration.
This
article
reviews
mechanism
action
in
treatment
osteoarthritis,
current
research
status
preparation
its
application
drug
therapy.
Journal of Orthopaedic Translation,
Journal Year:
2024,
Volume and Issue:
48, P. 53 - 69
Published: July 27, 2024
Joint
diseases
greatly
impact
the
daily
lives
and
occupational
functioning
of
patients
globally.
However,
conventional
treatments
for
joint
have
several
limitations,
such
as
unsatisfatory
efficacy
side
effects,
necessitating
exploration
more
efficacious
therapeutic
strategies.
Mesenchymal
stem
cell
(MSC)-derived
EVs
(MSC-EVs)
demonstrated
high
efficacyin
tissue
repair
regeneration,
with
low
immunogenicity
tumorigenicity.
Recent
studies
reported
that
EVs-based
therapy
has
considerable
effects
against
diseases,
including
osteoarthritis,
tendon
ligament
injuries,
femoral
head
osteonecrosis,
rheumatoid
arthritis.
Herein,
we
review
potential
various
types
MSC-EVs
in
aforementioned
summarise
mechanisms
underlying
specific
biological
MSC-EVs,
discuss
future
prospects
basic
research
on
MSC-EV-based
modalities
their
clinical
translation.
In
general,
this
provides
an
in-depth
understanding
well
mechanisms,
which
may
be
beneficial
to
translation
treatment.
The
translational
article:
cell-free
can
effectively
promote
regeneration
repair.
When
used
treat
desirable
preclinical
research.
This
supplement
further
treatment
its